Junbo Xia

602 total citations
23 papers, 421 citations indexed

About

Junbo Xia is a scholar working on Physiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Junbo Xia has authored 23 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Junbo Xia's work include Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (3 papers) and COVID-19 Clinical Research Studies (3 papers). Junbo Xia is often cited by papers focused on Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (3 papers) and COVID-19 Clinical Research Studies (3 papers). Junbo Xia collaborates with scholars based in China and United Kingdom. Junbo Xia's co-authors include Jing Zhu, Limin Wang, Yaping Xie, Changcheng Shi, Nengming Lin, Jian Ye, Qingyu Li, Renjie Xu, Zhi‐Chun Gu and Shuying Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Pharmacology and British Journal of Clinical Pharmacology.

In The Last Decade

Junbo Xia

22 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junbo Xia China 12 155 80 73 66 59 23 421
Ippazio Cosimo Antonazzo Italy 17 110 0.7× 75 0.9× 20 0.3× 46 0.7× 66 1.1× 53 617
Xiuqin Hong China 10 95 0.6× 76 0.9× 23 0.3× 33 0.5× 32 0.5× 29 363
Shengyuan Liu China 14 141 0.9× 136 1.7× 40 0.5× 71 1.1× 47 0.8× 34 539
Gökhan Çakırca Türkiye 12 85 0.5× 48 0.6× 52 0.7× 29 0.4× 17 0.3× 29 397
Manasvi Gupta United States 12 90 0.6× 142 1.8× 22 0.3× 37 0.6× 23 0.4× 28 685
Nadège Parassol France 9 126 0.8× 176 2.2× 98 1.3× 19 0.3× 31 0.5× 11 486
Alessandra Marchesi Italy 14 65 0.4× 131 1.6× 42 0.6× 116 1.8× 32 0.5× 34 731
Zhongde Zhang China 12 105 0.7× 136 1.7× 30 0.4× 56 0.8× 14 0.2× 36 459
Shahla Rezaei Iran 10 173 1.1× 83 1.0× 78 1.1× 22 0.3× 19 0.3× 31 601

Countries citing papers authored by Junbo Xia

Since Specialization
Citations

This map shows the geographic impact of Junbo Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbo Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbo Xia more than expected).

Fields of papers citing papers by Junbo Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbo Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbo Xia. The network helps show where Junbo Xia may publish in the future.

Co-authorship network of co-authors of Junbo Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Junbo Xia. A scholar is included among the top collaborators of Junbo Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbo Xia. Junbo Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xiao, et al.. (2023). Clinical value of serum soluble receptor for advanced glycation end products in evaluating the condition of patients with bronchial asthma. Allergy and Asthma Proceedings. 44(4). 258–264. 2 indexed citations
2.
Shi, Changcheng, Lei Qiu, Yingying Fang, et al.. (2023). Prevalence of inappropriate use of nirmatrelvir-ritonavir antiviral therapy in hospitalized patients: A multi-centre retrospective study in China. International Journal of Antimicrobial Agents. 62(2). 106857–106857. 6 indexed citations
3.
Jones, Paul, Ping Chen, Liping Chen, et al.. (2022). The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice. SHILAP Revista de lepidopterología. 11 indexed citations
4.
Shi, Changcheng, Limin Wang, Jian Ye, et al.. (2021). Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infectious Diseases. 21(1). 663–663. 111 indexed citations
5.
Shi, Changcheng, Qiyuan Shan, Junbo Xia, et al.. (2021). Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta‐analysis. Mycoses. 65(2). 152–163. 28 indexed citations
6.
Xia, Junbo, et al.. (2021). Serum exosomal microRNAs as predictive markers for EGFR mutations in non–small‐cell lung cancer. Journal of Clinical Laboratory Analysis. 35(5). e23743–e23743. 16 indexed citations
7.
Shi, Changcheng, Junbo Xia, Jian Ye, et al.. (2021). Effect of renal function on the risk of thrombocytopaenia in patients receiving linezolid therapy: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 88(2). 464–475. 24 indexed citations
8.
Wang, Qiang, Xuan Lin, Xiaochen Xiang, et al.. (2021). Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study. Frontiers in Bioengineering and Biotechnology. 9. 646184–646184. 21 indexed citations
9.
Xia, Junbo, et al.. (2019). Ganoderic acid DM induces autophagic apoptosis in non-small cell lung cancer cells by inhibiting the PI3K/Akt/mTOR activity. Chemico-Biological Interactions. 316. 108932–108932. 35 indexed citations
10.
Jin, Hualiang, Bei Li, Weizhong Jin, et al.. (2019). Modified Si–Jun–Zi–Tang Attenuates Airway Inflammation in a Murine Model of Chronic Asthma by Inhibiting Teff Cells via the mTORC1 Pathway. Frontiers in Pharmacology. 10. 161–161. 9 indexed citations
11.
He, Zhengguang, et al.. (2019). Frequency of Signs and Symptoms in Persons With Asthma. Respiratory Care. 65(2). 252–264. 19 indexed citations
12.
Zhu, Jing, Jie Jin, Jiexia Ding, et al.. (2018). Ganoderic Acid A improves high fat diet-induced obesity, lipid accumulation and insulin sensitivity through regulating SREBP pathway. Chemico-Biological Interactions. 290. 77–87. 37 indexed citations
13.
Wang, Limin, et al.. (2017). Astragaloside IV Ameliorates Airway Inflammation in an Established Murine Model of Asthma by Inhibiting the mTORC1 Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2017(1). 4037086–4037086. 21 indexed citations
14.
Xia, Junbo, Jing Zhu, Jun Hu, Limin Wang, & Hao Zhang. (2014). H7N9 Influenza A-induced Pneumonia Associated with Acute Myelitis in an Adult. Internal Medicine. 53(10). 1093–1095. 11 indexed citations
15.
Jin, Weizhong, Limin Wang, Junbo Xia, & Jian Ye. (2014). Three Cases of Avian-origin Influenza A (H7N9) Virus Infection in Zhejiang Province, China: Case Report and Literature Review. Internal Medicine. 53(20). 2397–2400.
16.
Bai, Chunxue, et al.. (2011). Immature dendritic cells expressing indoleamine 2,3-dioxygenase suppress ovalbumin-induced allergic airway inflammation in mice.. PubMed. 21(3). 185–92. 10 indexed citations
17.
Wang, Jiaoli, et al.. (2011). [The mechanism of airway inflammation in eosinophilic bronchitis and cough variant asthma].. PubMed. 34(6). 433–7. 5 indexed citations
18.
Xia, Junbo, et al.. (2009). [Immunoregulatory role of 1, 25-dihydroxyvitamin D(3)-treated dendritic cells in allergic airway inflammation].. PubMed. 89(8). 514–8. 5 indexed citations
19.
Wu, Kui, et al.. (2008). Suppression of Allergic Inflammation by Allergen‐DNA‐modified Dendritic Cells Depends on the Induction of Foxp3+ Regulatory T Cells. Scandinavian Journal of Immunology. 67(2). 140–151. 30 indexed citations
20.
Xia, Junbo, Kui Wu, Kun Sun, & Changzheng Wang. (2005). Amplification and identification of dendritic cells from mouse bone marrow. Europe PMC (PubMed Central). 27(10). 942–944. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026